Covered recipient · General Payments record
RANJANA ADVANI
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$139,938.59
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $12,932.50 | 3 |
| Travel and Lodging | $6,789.24 | 2 |
| Food and Beverage | $388.10 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| F. Hoffmann-La Roche AG | $15,311.47 | 5 |
| Genmab U.S., Inc. | $2,663.37 | 2 |
| Merck Sharp & Dohme Corporation | $2,135.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| F. Hoffmann-La Roche AG | $6,244.99 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133093484 | CMS |
| F. Hoffmann-La Roche AG | $8,360.00 | 04/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133093487 | CMS |
| F. Hoffmann-La Roche AG | $544.25 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133093491 | CMS |
| F. Hoffmann-La Roche AG | $146.23 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133093496 | CMS |
| F. Hoffmann-La Roche AG | $16.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133093500 | CMS |
| Genmab U.S., Inc. | $2,437.50 | 07/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1126831026 | CMS |
| Genmab U.S., Inc. | $225.87 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126831028 | CMS |
| Merck Sharp & Dohme LLC | $2,135.00 | 02/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141569640 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.